OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota: impacts on gastrointestinal cancer immunotherapy
Harry Cheuk-Hay Lau, Joseph J.�Y. Sung, Jun Yu
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 169

From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3

Indole metabolites and colorectal cancer: Gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms
Yufei Liu, Zhangming Pei, Tong Pan, et al.
Microbiological Research (2023) Vol. 272, pp. 127392-127392
Open Access | Times Cited: 29

The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23

Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers
Chunhao Cao, Siran Yue, Aiping Lu, et al.
Pharmacological Research (2024) Vol. 207, pp. 107321-107321
Open Access | Times Cited: 12

Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer
John Wen‐Cheng Chang, Jia‐Juan Hsieh, Chih‐Yu Tsai, et al.
Biomedical Journal (2024) Vol. 47, Iss. 5, pp. 100698-100698
Open Access | Times Cited: 8

Biomarkers, Omics and Artificial Intelligence for Early Detection of Pancreatic Cancer.
Kate Murray, Lucy Oldfield, Irena Stefanova, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 76-88
Closed Access | Times Cited: 1

Human Gut Microbiota in Health and Selected Cancers
Aleksandra Sędzikowska, Leszek Szablewski
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13440-13440
Open Access | Times Cited: 42

The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions
Despoina Eugenia Kiousi, Antonia Z. Kouroutzidou, Konstantinos Neanidis, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2101-2101
Open Access | Times Cited: 21

Biofilm-based delivery approaches and specific enrichment strategies of probiotics in the human gut
Jie Gao, Faizan Ahmed Sadiq, Yixin Zheng, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 22

IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling
Mircea T. Chiriac, Zsuzsanna Hracskó, Claudia Günther, et al.
Gut (2023) Vol. 73, Iss. 2, pp. 282-297
Open Access | Times Cited: 14

Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer
Jihan Wang, Yangyang Wang, Zhenzhen Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 28

Diet-gut microbial interactions influence cancer immunotherapy
Xue Wang, Shi-Tao Geng
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11

The Influence of the Microbiome on Immunotherapy for Gastroesophageal Cancer
Neda Dadgar, Vinay Edlukudige Keshava, Moses S. Raj, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4426-4426
Open Access | Times Cited: 9

Intestinal Mucosal Immune Barrier: A Powerful Firewall Against Severe Acute Pancreatitis-Associated Acute Lung Injury via the Gut-Lung Axis
Fan Li, Zhengjian Wang, Yinan Cao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2173-2193
Open Access | Times Cited: 3

Metabolic interactions of host-gut microbiota: New possibilities for the precise diagnosis and therapeutic discovery of gastrointestinal cancer in the future—A review
Jianing Yu, Lu Li, Xufeng Tao, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104480-104480
Open Access | Times Cited: 3

Gut microbiota dysbiosis is associated with sepsis‐induced cardiomyopathy in patients: A case‒control study
Fan Deng, Yu Chen, Qi‐Shun Sun, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 14

Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives
Stijn De Keukeleire, Tijl Vermassen, Elien Hilgert, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1714-1714
Open Access | Times Cited: 18

Nine-Gene Prognostic Signature Related to Gut Microflora for Predicting the Survival in Gastric Cancer Patients
Qing Yue, Wei Han, Zi Ling Lu
The Turkish Journal of Gastroenterology (2024) Vol. 35, Iss. 2, pp. 102-111
Open Access | Times Cited: 2

Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions
GuanBo Zhang, Jinsong Li, Gang Li, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Microbe-based management for colorectal cancer
Ziyun Gao, Zhe Cui, Yuqing Yan, et al.
Chinese Medical Journal (2021) Vol. 134, Iss. 24, pp. 2922-2930
Open Access | Times Cited: 16

Gut Microbiota Deficiency Exacerbates Liver Injury in Bile Duct Ligated Mice via Inflammation and Lipid Metabolism
Xueqian Zhou, Xiaoxun Zhang, Nan Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3180-3180
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top